0001209191-22-005261.txt : 20220127
0001209191-22-005261.hdr.sgml : 20220127
20220127183251
ACCESSION NUMBER: 0001209191-22-005261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220125
FILED AS OF DATE: 20220127
DATE AS OF CHANGE: 20220127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shendelman Shoshana
CENTRAL INDEX KEY: 0001775490
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 22564724
MAIL ADDRESS:
STREET 1: C/O APPLIED THERAPEUTICS, INC.
STREET 2: 340 MADISON AVENUE, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-25
0
0001697532
Applied Therapeutics Inc.
APLT
0001775490
Shendelman Shoshana
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK
NY
10017
1
1
1
0
President and CEO
Employee Stock Option (Right to Buy)
3.33
2022-01-25
4
A
0
234616
0.00
A
2032-01-25
Common Stock
234616
234616
D
Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Options to the Reporting Person in lieu of a cash bonus that otherwise would have been paid with respect to 2021. All of the shares subject to the compensatory Option vested immediately upon grant.
/s/ Shoshana Shendelman
2022-01-27